Pentoxifylline Effects on Hospitalized COVID-19 Patients with Cytokine Storm Syndrome: A Randomized Clinical Trial

Pentoxifylline Effects on Hospitalized COVID-19 Patients with Cytokine Storm Syndrome: A Randomized Clinical Trial

COVID-19 is a fatal, fast-spreading pandemic, and numerous attempts are being made around the world to understand and manage the disease. COVID-19 patients may develop a cytokine-release syndrome, which causes serious respiratory diseases and, in many cases, death. The study examined the feasibility...

Full description

Bibliographic Details
Main Authors: Rania M. Sarhan, Ahmed E. Altyar, Ahmed Essam Abou Warda, Yasmine Mohamed Saied, Haytham Soliman Ghareeb Ibrahim, Mona F. Schaalan, Shaimaa Fathy, Neven Sarhan, Marian S. Boshra
Format: Article
Language:English
Published: MDPI AG 2023-04-01
Series:Pharmaceuticals
Subjects:
pentoxifylline
severe acute respiratory syndrome
cytokines release syndrome
COVID-19
Online Access:https://www.mdpi.com/1424-8247/16/4/631

Internet

https://www.mdpi.com/1424-8247/16/4/631

Similar Items